Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced detailed results from CORALreef AddOn, an active comparator study designed to evaluate the efficacy and safety ...
The White House has delayed nominating a new director of the Centers for Disease Control and Prevention and is continuing a search, according to officials, as the Trump administration navigates ...
The Trump administration has hit its legal limit for leaving the position of director of the Centers for Disease Control and Prevention (CDC) vacant after firing the sitting director last year. Former ...
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced detailed results from CORALreef AddOn, an active comparator study designed to ...
The Phase 3 CORALreef AddOn trial compared the efficacy and safety of enlicitide to bempedoic acid, ezetimibe or bempedoic acid with ezetimibe Enlicitide has the potential to be the first approved ...
Merck & Co. has lifted the lid on the third successful phase 3 trial of its PCSK9 inhibitor, showing the edge the cardiovascular disease prospect has over other oral non-statin therapies. Last year, ...
President Trump will soon nominate a permanent director for the Centers for Disease Control and Prevention, its acting chief, National Institutes of Health Director Jay Bhattacharya, told agency ...
March 26 (UPI) --The Trump administration has missed a legal deadline to nominate a new director of the Centers for Disease Control and Prevention after the ouster of Susan Monarez in August. Federal ...
The White House won’t meet an expected Wednesday deadline to nominate a new director of the Centers for Disease Control and Prevention. Subscribe to read this story ad-free Get unlimited access to ...
Please provide your email address to receive an email when new articles are posted on . Enlicitide lowered lipids to a greater degree than other drugs in high-risk statin-treated patients. The oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results